Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
lorlatinib
.
Show all posts
Showing posts with label
lorlatinib
.
Show all posts
Monday, March 6, 2017
Pfizer Presents Promising Data from Next Generation ALK/ROS1 Inhibitor in Advanced Non-Small Cell Lung Cancer
›
Pfizer Inc. announced encouraging new data from a Phase 1/2 study of lorlatinib, the proposed generic name for PF-06463922, Pfizer’s in...
›
Home
View web version
